Introduction {#S1}
============

Cholangiocytes, the epithelial cells lining the biliary tree, not only have important physiologic functions, but also are the target of a group of diseases known as the cholangiopathies, one of which is primary sclerosing cholangitis (PSC), an incurable, idiopathic, fibroinflammatory syndrome ([@R1]). While the pathogenesis of PSC is unclear, we recently reported that cholangiocyte senescence is an important phenotype in patients with PSC ([@R2]). Moreover, Cameron and colleagues reported the accumulation of perisinusoidal macrophages into the bile ducts of patients with PSC ([@R3]). Unfortunately, well defined *in vitro* models to pursue these observations and further interrogate the pathogenesis of PSC are limited. For example, studying biliary diseases with existing two-dimensional (2D), *in vitro* techniques on tissue culture dishes has shortcomings, including: i) plastic surfaces are several orders of magnitude stiffer than the physiologic environment ([@R4]); ii) tissue culturing on plastic surfaces does not recapitulate physiologic cell-cell and cell-microenvironment interactions; and iii) on 2D plastic, it is not possible to observe a ductal lumen as well as changes in bile duct anatomy or physiology such as bile duct obliteration. Recently, advances in the field of *in vitro* research have been made with the introduction of three-dimensional (3D) cell culturing techniques, as 3D cultures can be made to resemble the morphology of organs and recapitulate better *in vivo* biologic processes ([@R5]). 3D *in vitro* cellular clusters that exhibit spontaneous formation, growth, and polarity, termed organoids, have been generated from embryonic stem cells, pluripotent stem cells, as well as from a number of primary cell types ([@R6]--[@R9]). To date, several manuscripts have described the development of 3D cultures from cholangiocytes, the majority of them reporting the formation of 3D cultures of cholangiocytes that were differentiated from pluripotent or embryonic stem cells ([@R10]--[@R13]) using this approach to model biliary diseases such as Alagille syndrome, polycystic liver disease, and cystic fibrosis ([@R10], [@R11]). More recently, Spirli and colleagues generated organoids from cholangiocytes from mice with polycystic liver disease and studied the effects of adenylyl cyclase inhibition on organoid size ([@R14]). Also, Waisbourd-Zinman and colleagues demonstrated a link between a plant derived toxin and development of biliary atresia-associated cellular changes using 3D cultures of mature and freshly isolated extrahepatic neonatal mouse cholangiocytes ([@R15]). Previously, using collagen matrices, our group reported the formation of 3D hepatic cysts from bile ducts from normal rats and rats with polycystic kidney disease ([@R16]). Thus, to extend and refine these efforts, our objectives here were to: i) develop a simple, reproducible 3D *in vitro* model of normal human and diseased cholangiocytes, which we have termed cholangioids, beginning with cholangiocyte cell lines; ii) characterize the morphology, size, cell number, and polarity of the cholangioids; iii) assess the functionality of the cholangioids; and iv) begin to utilize our model to mimic selected features of PSC, such as cellular senescence and macrophage recruitment. Herein, we describe a novel, *in vitro* 3D model of PSC, which will be useful to understand the mechanisms of PSC pathogenesis, the interactions between PSC bile ducts and immune cells, and potentially to develop new therapeutic targets.

Materials and Methods {#S2}
=====================

The normal human cholangiocyte cell line (NHC) was isolated from a normal human liver and characterized by Joplin and colleagues ([@R17]) and was a gift from Dr. Juan Medina (University of Navarra, Pamplona, Spain). NHCs passages 10--15 were used in this study. We also used a cell line derived from a patient with PSC previously described by us ([@R18]). The human macrophage THP-1 cell line was purchased from the American Type Culture Collection (Manassas, VA) and cultured according to their protocol.

Cholangioid media {#S3}
-----------------

Media previously reported for culturing cholangiocytes in monolayers (H69 media) ([@R19]) was supplemented with 5 ng/ml of recombinant epidermal growth factor (EGF) (Sigma-Aldrich) and 5% of growth factor reduced, phenol free Matrigel (Corning, New York, NY).

3D cultures {#S4}
-----------

To prevent the growth of cells in monolayer, tissue culture dishes or glass slide chamber slides were pre-coated with a polyHEMA (Sigma-Aldrich, St. Louis MO) solution (125 μl/cm^2^) ([@R20]). A cell suspension containing 6250 NHCs or PSC cells and 56 μls of growth factor reduced, phenol free Matrigel/cm^2^ was plated on the polyHEMA-coated surfaces and incubated at 37°C, 5% CO~2~ for 2 h as reported elsewhere ([@R21]). Then, 250 μl of cholangioid media were added per well. Cholangioid media was changed every four days and cells kept in culture for 5--20 days.

Isolation and counting cells of cholangioids {#S5}
--------------------------------------------

Five and twenty day single cholangioids of up to 150 μm were isolated by manually pipetting using 10 μl pipettes and a Zeiss Axiovert 25 microscope. The cholangioids were placed in 25 μl of Dispase (Corning) and incubated at 37°C, 5%CO~2~ for 2 h to dissociate the cells. Single cells were counted using a hemocytometer and trypan blue. The cholangioid size was calculated by averaging the vertical, horizontal, and diagonal diameters of each cholangioid using the ImageJ software.

Phase contrast and confocal live microscopy {#S6}
-------------------------------------------

Pictures of five and twenty day cholangioids were taken via phase contrast, differential interference contrast (DIC), and confocal microscopy using a Nikon Eclipse TE 300 and a Zeiss LSM 780 microscopes.

Immunofluorescent Microscopy {#S7}
----------------------------

Cholangioids were fixed with 4% paraformaldehyde, permeabilized for 45 min at 4°C ([@R21]), blocked with 1% donkey serum, and incubated over night at 4°C with antibodies to the following proteins: GM130 (Novus Biologicals, Littleton, CO), SR, CK7, and CK19 (Santa Cruz Biotechnology), acetylated tubulin (Sigma-Aldrich), IL-6, γH2A.x, CFTR, AE2 and CD11B (Abcam, Cambridge, MA). All antibodies were used at a concentration of 1:100. Following 3 washes, the cholangioids were incubated with the following secondary antibodies diluted at 1:400: donkey anti-goat IgG-568, donkey anti-rabbit IgG-488, and donkey anti-mouse-647 (Abcam). Then nuclei were counterstained with DAPI and the chamber slides were stored at 4°C in 20% glycerol/phosphate buffered saline (PBS).

Transmission electron microscopy (TEM) {#S8}
--------------------------------------

Twenty day cholangioids were fixed in 2.5% glutaraldehyde/0.1 M phosphate buffer (PB) at pH 7.4 for 1h at room temperature. Then, the cholangioids were washed in 0.1 M phosphate buffer (PB; pH 7.2--7.4) and incubated with 1% OsO~4~ in PB for 1 h. After rinsing with PB twice and four times with distilled water, the samples were dehydrated, and then embedded in Spurrs resin and sectioned at 90 nm. Pictures were taken using a Joel 1400 electron microscope (Joel USA, Peabody, MA).

Immunogold transmission electron microscopy (IG-TEM) {#S9}
----------------------------------------------------

Pellets of exosomes (see below for isolation) were fixed in 4% paraformaldehyde/0.1 M PB (1:1 in volume) for 2 h or overnight at 4°C. The samples were then placed on Formvar-carbon-coated nickel grid (200 mesh) and air dried for 30 min. After saturation of free aldehyde groups by 2% FCS/PBS (Fetal calf serum) containing 20 mmol/L glycine for 20 min and blocked with 10% FCS/PBS for 20 min, the grids were incubated with TSG 101 antibody (Santa Cruz, goat M-19) diluted 1:20 with 10% FCS/PBS for 2 h or overnight at 4°C. After washing with 2% FCS/PBS 6 times (5 min each) and then labeled with rabbit anti-goat IgG (Sigma) in 1:500 dilution with 10% FCS/PBS for 1 h, then labeled with protein A-10 nm gold (1:20 diluted with 10% FCS/PBS). The grids were post-fixed with 1% Glutaraldehyde/PBS for 5 min, washed 6 times with distilled water drops (3 min each). Then, the grids were contrasted and embedded with a mixture of 4% uranyl acetate and 2% methylcellulose (in 1:9 ratio). The grids were air dried and observed with JEOL 1400 electron microscope.

Western Blotting {#S10}
----------------

Approximately, 5--10 μg of protein were run on 4--20% Mini-PROTEAN®TGX™ precast polyacrylamide gels (Bio-Rad Laboratories, Inc., Hercules, CA), transferred to nitrocellulose membranes, blocked, and probed with primary antibodies for: CD63, ALIX, TSG101, Actin, CK7, CK19, GGT1 diluted 1:500 (Santa Cruz Biotechnology). The secondary antibody, donkey-anti-rabbit or mouse-HRP (Jackson Labs, West Grove, PA) was diluted 1:10,000. The signal was developed with the ECL Western Blotting System (GE Healthcare, Little Chalfont UK) using a Kodak X-Omat (Rochester, NY).

RNA Extraction and Quantitative Real Time PCR {#S11}
---------------------------------------------

Twenty day cholangioids from NHC-control and NHC-sen were collected using Cell Recovery Solution (Corning Inc., Corning, NY) according manufacture's protocol. Total RNA was extracted from cholangioids using the RNeasy Plus Mini Kit (Qiagen). Reverse transcription was performed with 1 μg RNA, using oligo (dT) primer and SuperScript III. Real-time PCR was performed in a volume of 20 μl using Sybr Green Master Mix and QuantStudio3 (Applied Biosystems).

Exosome isolation {#S12}
-----------------

Twenty day cholangioids were washed in serum free H69 media 3 times. Then, the cholangioids were incubated in serum free H69 media for 24 h at 37°C, 5% CO~2.~ The conditioned media was collected and processed for differential ultracentrifugation to isolate exosomes as described previously ([@R22]).

Secretin assays {#S13}
---------------

Twenty day cholangioids were incubated with vehicle or 100 nM recombinant human secretin (Sigma-Aldrich) and stained with 1:1000 Cell MaskOrange Plasma membrane stain (Life Technologies, Carlsbad CA) for 15 min at 37°C, 5% CO~2~. After two washes with cholangioid media, live images where taken using a Zeiss LSM 510 microscope.

Experimentally induced senescence of cholangioids {#S14}
-------------------------------------------------

To induce senescence, NHCs were cultured in Matrigel for 20 days as described earlier to generate cholangioids. The next day, after plating the 3D cultures, the cholangioids were treated with 50 nM H~2~O~2~ every other day ([@R2]).

β-gal assays {#S15}
------------

For the colorimetric β-gal assays, twenty day cholangioids were washed 3 times with PBS and fix them for 15 min at room temperature. Following 3 washes with PBS, the cholangioids were incubated with the X-gal solution for 4 h at 37°C, 5% CO~2~ (Cell Biolabs, Inc. San Diego, CA).. The cholangioids were washed 3 times with PBS before adding 20% glycerol/PBS. The samples were stored at 4°C before taking pictures at 20X with a Nikon Eclipse TE 300. For the quantitative assay, a fluorescence β-gal kit was used. The cholangioids were washed and incubated with the SA-β-Gal substrate according to the manufacturer's instructions. Fluorescence was read using a Synergy H1 microplate reader, Biotek.

Freezing cholangioids and culture of frozen cholangioid-stocks {#S16}
--------------------------------------------------------------

Media was pipetted out from twenty day cholangioids that were grown in 35 mm dishes. Approximately 1 ml of cold cholangioid media was added to the dish placed on ice. The media was pipetted up and down several times until the Matrigel was dissolved and transferred to a conical tube and spun for 3 min, 4°C, 1500 rpm. The media was aspirated and the pellet resuspended in cold cholangioid media containing 10% DMS0 and 10% growth factor reduced, phenol free Matrigel and stocks prepared in cryovials. The cryovials were placed at −80°C for 24 h and then stored in liquid N~2~. To culture frozen cholangioid stocks, the cryovial was placed in a water bath at 37°C for 1 min. The cholangioid suspension was mixed with cold cholangioid media and spun for 3 min at 4°C, 1500 rpm. After aspirating the media, the tube was placed in ice and the pellet resuspended in 450 μl of growth factor reduced, phenol free Matrigel. Then the cholangioid-Matrigel suspension was placed on a polyHEMA coated 35 mm dish as described earlier.

Co-cultures {#S17}
-----------

Approximately 10,000 THP-1 cells in suspension were incubated with 20 day old NHC and PSC cholangioids cultured in glass slide 8-well chamber slides for 24 h at 37°C, 5% CO~2~ in cholangioid media. Then the co-cultures were processed for live images or immunofluorescence.

Cell Migration Assay {#S18}
--------------------

Human monocytic THP-1 cells (TIB-202, ATCC) were plated at 200,000 cells/well in the upper chamber of a 96-well migration assay (Cell Biolabs, Inc. San Diego, CA) and incubated for six hours with conditioned media (bottom chamber) obtained from NHC-Ctrl or NHC-Sen organoids or with media only as a negative control. THP-1 cell migration was then quantitated per manufacturer's instructions.

Statistical Analysis {#S19}
--------------------

The data reported represents the mean of 5--12 cholangioids per experiment or fold change ± standard error of the mean. The results were analyzed using Graphpad Prism by two tailed, paired, or unpaired t test. P values of \<0.05 were considered statistically significant.

Results {#S20}
=======

Development and characterization of cholangioids {#S21}
------------------------------------------------

Live images of 5 and 20 day cholangioids using phase contrast and DIC microscopy ([Fig. 1A](#F1){ref-type="fig"}) showed that, in Matrigel, NHCs form spheroid-like structures that increase in size ([Fig. 1B](#F1){ref-type="fig"}) and cell number ([Fig. 1C](#F1){ref-type="fig"}). After 20 days in culture, cholangioids start forming tubular structures resembling bile ducts ([Fig. 2A--B](#F2){ref-type="fig"}). Immunofluorescence analysis showed that cholangioids are polarized structures demonstrated by the expression of the Golgi protein, GM130, that has been used as an apical marker in 3D cultures as it shows the localization of the Golgi apparatus towards the lumen of hollow spheroids ([@R21]), as well as the secretin receptor (SR) on the basolateral domain of cholangioids ([Fig. 3A--B](#F3){ref-type="fig"}). Immunofluorescence and electron microscopy showed that cholangioids also possess primary cilia that extend into a hollow lumen ([Fig. 3C](#F3){ref-type="fig"} and [Fig. 4C](#F4){ref-type="fig"}). Moreover, studies performed with 3D structures of other cell types showed that spheroids are hollow structures and that their lumens are formed as the cells in the middle die via apoptosis and autophagy dependent mechanisms ([@R21], [@R23], [@R24]). Electron microscopy analysis shows the luminal space and remnants of dead cells of a cholangioid and the ultrastructure of the NHCs forming cholangioids depicts the cytoskeleton, nucleus, a multivesicular body, and tight junctions between cells, as well ([Fig. 4A, B, D](#F4){ref-type="fig"}). A 3D reconstruction of the z-stacks taken via confocal microscopy confirms that indeed cholangioids have a hollow internal structure ([Suppl. Fig. 1](#SD1){ref-type="supplementary-material"}). Moreover, NHCs forming cholangioids retain expression of the cholangiocyte markers CK7, CK19, and GGT1 ([Fig. 3D--F](#F3){ref-type="fig"}). Immunofluorescence also showed that cholangioids express CFTR, a cell surface chloride transporter, as well as the anion exchanger, AE2 ([Suppl. Fig. 2](#SD2){ref-type="supplementary-material"}). We were also able to make stocks of frozen NHC-cholangioids, store them for 8 months in liquid N~2,~ re-culture them, and show that they maintain their morphology and cholangiocyte marker expression ([Suppl. Fig 3](#SD3){ref-type="supplementary-material"}).

Functional features {#S22}
-------------------

As cholangiocytes are known to respond to secretin, we stimulated cholangioids with recombinant human secretin to test whether cholangioids were functionally active. We found that secretin induced a 75.9 ± 6.4% increase (p\<0.01) in the cholangioid luminal area ([Fig. 5](#F5){ref-type="fig"}) showing that NHC-derived cholangioids are responsive to secretin and are functionally active.

Pathophysiology {#S23}
---------------

Our previous studies indicated that cholangiocyte senescence is an important cellular phenotype in PSC and that cholangiocytes in liver biopsies from PSC patients express increased levels of the SASP pro-inflammatory factors IL-6, IL-8, CCL2, PAI-1 ([@R2]). We also reported that cholangiocytes isolated from PSC patients show characteristics of cellular senescence, i.e., SA-β-gal expression as well as markers of SASP, such as, IL-6, IL-8 and CCL2 expression ([@R18]). Furthermore, previously we were able to induce senescence of NHCs on cholangiocyte monolayers using hydrogen peroxide (H~2~O~2~) ([@R2]) and we were able to reproduce that outcome here in cholangioids ([Fig 6](#F6){ref-type="fig"}). In addition, we were also able to recapitulate the senescence phenotype in our 3D model by using a cholangiocyte cell line from a patient with PSC that was previously isolated and characterized by our group ([@R18]). We confirmed senescence using a qualitative SA-β-gal assay as shown on [Fig. 6A](#F6){ref-type="fig"}. A quantitative SA-β-gal technique demonstrated 1.62 ± 0.02 and 2.64 ± 0.09 fold increase senescence over control for the NHC-sen and PSC cholangioids respectively (p\<0.02) ([Fig. 6B](#F6){ref-type="fig"}). Western blotting analysis depicted an increase in the senescence marker p-16 with the H~2~O~2~ treatment and in PSC cholangioids ([Fig. 6C](#F6){ref-type="fig"}), consistent with the previous reports from our group. We also detected the expression of the senescent marker γH2A.x and the SASP marker IL-6 via immunofluorescence ([Fig. 6D](#F6){ref-type="fig"}) and found that the mean fluorescence intensity of the NHC-sen cholangioids was upregulated 8.8 ± 1.4 and 12.7 ± 3.4 fold for γH2A.x and IL-6 respectively over the control cholangioids (p\<0.01) ([Fig. 6E](#F6){ref-type="fig"}). Interestingly, we observed that 41 ± 16 % of the NHC-sen cholangioids and virtually all of the PSC cholangioids failed to form lumens; in contrast all the NHC-cholangioids formed lumens. Quantitative phase contrast imaging showed that NHC-sen cholangioids displayed a smaller diameter and a slower rate of growth as they progressed from day 5 to day 20 ([Fig. 7A](#F7){ref-type="fig"}). A similar size reduction was observed in PSC cholangioids as well ([Fig. 7B](#F7){ref-type="fig"}). Unlike the NHC-cholangioids, the PSC cholangioids did not exhibit polarized distribution of GM130 and the SR and secretin stimulation did not result in an increase in PSC cholangioid size (data not shown). Our lab has previously reported that senescent cholangiocytes become highly secretory including the release of extracellular vesicles (EVs) or exosomes. Here we show that the senescent cholangioids also become highly secretory. Based on Q-PCR studies, the senescent cholangioids upregulate typical markers of senescence such as P21, β;Gal, and p16 and generate increased levels of pro-inflammatory cytokines such as CCL2 and IL-8 ([Fig. 8A](#F8){ref-type="fig"}). Consistent with this secretory phenotype, senescent cholangioids also release an increased number of EVs ([Fig. 8B](#F8){ref-type="fig"}). These EVs, when characterized by immunoblotting, are positive for exosomal markers such as FN, Alix, TfR and Cd81 ([Fig. 8C](#F8){ref-type="fig"}). Nanotracking analysis (NTA) also shows the size of these EVs to be around 106nm, consistent with the size of exosomes ([Fig. 8D](#F8){ref-type="fig"}). Due to the limited availability of PSC cells, we were not able to generate PSC cholangioids to isolate exosomes.

Next, to test if we could recapitulate the macrophage accumulation phenotype of PSC([@R3]) in our model, we co-cultured normal and PSC cholangioids with a commonly used human macrophage cell line, THP-1 ([@R25], [@R26]). After 24 h in culture, the co-cultures were fixed and stained for CK7 and CD11B, the former a marker for cholangiocytes and the latter a marker of macrophage activation ([Fig. 9A](#F9){ref-type="fig"}). The number of THP-1 cells associated with PSC cholangioids was 7.6 ± 1.6 (p\<0.03) compared to 1.3 ± 0.6 for the control cholangioids ([Fig. 9B](#F9){ref-type="fig"}). Furthermore, conditioned media experiments revealed that cell-free media derived from NHC-sen cholangioids resulted in a 2-fold increase in the migration of THP-1 cells, compared to media derived from NHC-Ctrl cholangioids ([Fig. 9C](#F9){ref-type="fig"}).

Discussion {#S24}
==========

In this manuscript, we describe the establishment and characterization of cholangioids, a novel, 3D model of cultured cholangiocytes to study the pathogenesis of PSC. Beginning with cholangiocyte cell lines, we generated 3D spheroids that resemble bile ducts, describing them morphologically and biochemically, and demonstrating that these cholangioids have functional features of both normal and senescent cholangiocytes. The data support the utility of this *in vitro* model to study the pathogenesis of PSC and perhaps other cholangiopathies. Also, to our knowledge, this is the first report describing isolation of exosomes from normal and senescent human cholangiocytes in 3D culture. The SASP is a characteristic feature of senescent cells and is increasingly thought to play a pathophysiologic role in biliary disease([@R2]). Given that cellular senescence is a prominent feature of the cholangiocytes from patients with PSC, generating a 3D culture model that maintains the functional features of senescence and the SASP represents an important advance.

The method we describe in this manuscript was a modified version of the protocol described by Debnath and colleagues ([@R21]). The advantages of using this method were that: i) we could monitor the growth of the cholangioids via bright field microscopy very easily; ii) the growth of the cholangioids was consistent across different experiments; iii) live images of the cholangioids interacting with macrophages using confocal microscopy could be performed and these same samples could then be fixed for immunofluorescence analysis; and iv) the immunofluorescence technique in this protocol is very simple. Since we cultured our cholangioids for 20 days, our protocol required the use of undiluted Matrigel, as diluting it compromises the formation of the 3D structure. The ability of cholangioids to form lumens allows manipulation of lumen size, as we did with secretin, an assay that cannot be performed on cells cultured on plastic. Furthermore, interactions between cells and their extracellular microenvironment and changes in the stiffness of the extracellular microenvironment are better visualized in a 3D compared to a 2D model. Thus, our 3D *in vitro* model has several advantages compared to cells cultured on plastic.

Several groups have shown that cholangiocytes form spheroids with a lumen in 3D culture ([@R10], [@R27]--[@R30]), however this is the first report showing that senescent cholangioids, both experimentally induced or derived from PSC cholangiocytes, lack a lumen. The failure to form lumens could be a hallmark of PSC disease, as half of our NHC-sen and all of our PSC cholangioids did not form lumens. The reasons for this consistent observation remain unclear at this time. However, Tanimizu, et al., showed that organoids that failed to form a luminal space were weakly positive for CK19 and had high expression of albumin([@R28]). Another group also showed that albumin−/CK19+ cells form more and larger organoids when compared to albumin+/CK19− organoids ([@R31]). Overall, this suggests that lumens are better-formed in organoids that highly or exclusively express cholangiocyte markers with a relative lack of hepatocyte markers. Western-blot analysis of NHC-control and NHC-sen cholangioids showed similar levels of CK7 and CK19 expression ([Fig. 6C](#F6){ref-type="fig"}) and both cholangioids lack expression of albumin (data not shown). We have, at this point, no mechanistic explanation for why NHC-sen and PSC cells lack a central lumen, but we speculate that the percentage of cells in each of these cholangioid subtypes that were senescent may contribute to the differences. While senescence is defined as terminal growth arrest, it is notable that the senescent and PSC-cholangioids were still able to form cholangioids. We believe that the explanation for this is that the cells in this system are not uniformly senescent. The ability to expand and form cholangioids likely depends primarily on the non-senescent components of this model. Consistent with this, senescent and PSC cholangioids are smaller and have a slower growth rate than the corresponding controls, as would be expected if a proportion of the cells are senescent.

Macrophages are important cells of the immune system that are mobilized in response to an infection or accumulating damaged cells. The immunopathogenesis of PSC appears to involve the activation and recruiting of the innate immune system ([@R3]). Here we showed that our NHC-sen cholangioids retain the expression of profibroinflammatory SASP components ([@R2], [@R18]). Co-culture of macrophages with cholangioids demonstrated that macrophages associate with and appear to be intercalated within the PSC cholangioid walls. The mechanisms of this phenomenon and the consequences of this cell-cell interaction remain to be determined, and our model provides an ideal system to interrogate this observation further.

In conclusion, studies on the pathogenesis of PSC have been hindered by the lack of a reliable 3D *in vitro* model of this disease. The model presented in this work recapitulates the senescence and SASP as well as the macrophage recruitment observed in PSC. The mechanisms by which macrophages are recruited to PSC can be studied with this model and the broader question of how activated cholangiocytes interact with cells in the peribiliary extracellular matrix can be explored.
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![3D formation of cholangioids\
**(A)** Live images of 5 day and 20 day 3D cultures of NHCs in Matrigel. **(B)** Pictures were taken using phase-contrast (20X) or DIC (63X) microscopy. **(C)** Individual cholangioids where imaged and isolated after days 5 and 20 in culture. The cholangioids were disassembled into individual cells, which were counted using trypan blue, n=3, \**p\<0.0****5***. Diameter measurements were taken on the pictures of the isolated 5 and 20 day cholangioids using ImageJ. The data shown is representative of triplicate experiments, \**p\<0.05*.](nihms879671f1){#F1}

![Tubular-like structure formation from NHC-cholangioids\
**(A)** NHCs were cultured in Matrigel for 20 days to form cholangioids. Tubular-like structures were also formed as shown by bright field (20X) **(B)** and confocal (63X) microscopy, blue represents nuclei stained with DAPI.](nihms879671f2){#F2}

![NHC-cholangioids are polarized and retain cholangiocyte markers\
**(A)** Immunofluorescence of the polarity markers GM130 on the apical side, scale bar = 10 μm **(B)**, the secretin receptor (SR) located on the basolateral membrane, scale bar = 50 μm, **(C)** acetylated tubulin on the apical side extending into the lumen, insert showing and enlarged picture of a primary cilium, scale bar = 50 μm, **(D)** and the cholangiocyte markers CK7, scale bar = 50 μm **(E)** and CK19, scale bar = 50 μm**. (F)** Western blot of the cholangiocyte markers GGT1, CK7 and CK19 and Actin from cholangioid lysates.](nihms879671f3){#F3}

![The ultrastructure of NHC-cholangioids via electron microscopy\
NHCs were cultured in Matrigel for 20 days to form cholangioids before fixation and processing for electron microscopy. **(A)** Cross section of a cholangioid showing a layer of live cells with apical and basolateral polarity and a luminal area formed by residual of dead cells. **(B)** Higher magnification showing the cytoskeleton of NHCs**. (C)** Red arrow pointing at partial cilium extending into the lumen and dashed red arrow showing a multivesicular body**. (D)** Red arrow pointing at tight junctions between NHCs.](nihms879671f4){#F4}

![Secretin induces NHC-cholangioid size\
**(A)** NHCs were cultured for 20 days in Matrigel to form cholangioids. Cholangioids were treated with vehicle or 100 nM human recombinant secretin for 15 min and CellMask Orange Plasma membrane stain 1:1000. After two washes with cholangioid media, live images were taken at 63X using confocal microscopy**. (B)** Average of measurements of vertical, horizontal, and diagonal diameters taken using ImageJ were recorded. The data shown is representative of triplicate experiments, \**p\<0.01*.](nihms879671f5){#F5}

![H~2~O~2~ induces NHC-cholangioid senescence\
NHCs or PSC cells were grown in Matrigel for 20 days to form cholangioids. **(A)** Control, NHC-sen, and PSC cholangioids were processed for a qualitative β-gal assay and bright field pictures. Blue color represents senescent cholangioids. Control and NHC-sen, scale bars = 100 μm, PSC scale bar = 50 μm and **(B)** a quantitative fluorescent β-gal assay showing fold senescence over control cholangioids is depicted, n=3, \*p\<0.05**. (C)** Western blot of CK7, CK19 and p16 from NHC-control, NHC-sen (left), densitometry for p16 (right). **(D)** Control and NHC-sen cholangioids were fixed and processed for immunofluorescence and stained for the senescent and SASP markers γH2A.x and IL-6, respectively. Insert showing an enlarged picture of the punctuated pattern of γH2A.x and IL-6 staining**. (E)** Mean fluorescence intensity of γH2A.x and IL-6 was measured using ImageJ and fold change over control was calculated. The data shown is representative of triplicate experiments, \**p\<0.01*.](nihms879671f6){#F6}

![Senescent cholangioids display smaller diameter and reduced growth rate\
**(A)** Quantification of phase contrast from NHC-control and NHC-Sen during 5, 10 and 20 days of 3D culture, showed that NHC-Sen generate smaller cholangioids and a slower growth rate compared to NHC-Control. **(B)** A similar size reduction was observed in PSC cholangioids after 20 days in 3D culture.](nihms879671f7){#F7}

![NHC-sen cholangioids are secretory\
**(A)** Real-Time PCR showed an enrichment of senescent markers (P21, B-Gal, CCL2, IL-8 and P16) in NHC-Sen cholangioids when compared to NHC-Control cholangioids. **(B)** Media from 21 day cholangioids was collected and processed for exosome isolation. Nanoparticle tracking analysis showing an increased concentration (particles/ml) in NHC-Sen. **(C)** Western blot of the exosomal markers Alix, CD68 and TSG101 from exosomes released by cholangioids. **(D)** Nanoparticle tracking analysis showing the size of exosome isolation from cholangioids. \*\**p*≤ *0.05*. All PCR data are normalized to GAPDH and NHC-Control cholangioid expression is set to 1.0. The data shown is representative of triplicate experiments, \**p\<0.01*.](nihms879671f8){#F8}

![Co-culture of THP-1 cells with NHC and PSC cholangioids\
**(A)** NHC and PSC cholangioids were co-cultured with THP-1 cells for 24h. The co-cultures were fixed and stained for CK7 in green and CD11B in red**. (B)** The number of THP-1 cells associated per cholangioid was counted and plotted in a bar graph. **(C)** THP-1 cells were exposed to conditioned media from NHC or NHC-Sen and subjected to a migration assay. The data shown is representative of triplicate experiments, \*\**p\<0.005*.](nihms879671f9){#F9}
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